George Ueda
Co-Founder and CTO at Archon Biosciences
George Ueda is Co-Founder and CTO at Archon Biosciences, a startup focused on designed protein therapeutics. His expertise includes developing protein therapeutics.
Archon Biosciences Raises $20M to Develop AI-Optimized Antibody Cages for Disease Treatment
Archon Biosciences has emerged from stealth with $20 million in seed funding led by Madrona Ventures to develop Antibody Cages, computationally designed protein structures optimized with AI for treating cancer and other diseases. The technology builds on protein design research linked to a recent Nobel Prize awarded to University of Washington biochemist David Baker.
Organizations
See all 7-
Archon Biosciences Co-Founder and CTO 2023–present · current
-
Institute for Protein Design, University of Washington Acting Instructor - Translational Investigator 2021–2024 · past
-
Lumen Biosciences Consultant 2018 · past
Education
-
UW Medicine Doctor of Philosophy - PhD, Biochemistry · 2013–2018
-
University of Washington Bachelor of Science (BS), Biochemistry · 2009–2013
